2025.Sep.01

Corporate

OBI Pharma, Inc. Announces Board Resolution for Capital Reduction to Offset Accumulated Losses and Holds Material Information Press Conference

On September 1, 2025, the Board of Directors of OBI Pharma, Inc. resolved to conduct a capital reduction to offset accumulated losses. A press conference was held at 3:30 p.m. on the same day at the Taipei Exchange to provide further explanation.

HOMEWhat’s NewNewsOBI Pharma, Inc. Announces Board Resolution for Capital Reduction to Offset Accumulated Losses and Holds Material Information Press Conference

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2025.Aug.31

OBI Pharma Announces Phase 1/2 Study Initiation for OBI-902, a TROP2 Targeted Antibody-Drug Conjugate Therapy (ADC) in Advanced Solid Tumors

2025.Sep.01

OBI Pharma, Inc. Announces Board Resolution for Capital Reduction to Offset Accumulated Losses and Holds Material Information Press Conference